CDC37 and cancer: Moreover, researchers synthesized a celastrol analog based on its structure and found that the analog significantly disrupted HSP90-Cdc37 protein interaction and induced apoptosis in cancer cells by binding (hydrogen and/or covalent bonding) to Cdc37 105.